US 12180272
Antigen binding molecule formats
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 12180272 (Antigen binding molecule formats) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61K47/6845, A61K47/6849